Organization · Venture Capital
Militia Hill Ventures
Militia Hill Ventures is a venture creation firm based in the Philadelphia area that focuses on building and investing in life sciences companies. They leverage their extensive network and expertise to develop innovative therapies and generate returns for investors.
Overview
What Militia Hill Ventures does
What Militia Hill Ventures is
Militia Hill Ventures is a venture creation firm based in the Philadelphia area that focuses on building and investing in life sciences companies. They leverage their extensive network and expertise to develop innovative therapies and generate returns for investors.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2013
- Approximate age
- About 13 years
- Structured capabilities
- Funder
- Last reviewed
- April 24, 2026
Official channels
Find Militia Hill Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Militia Hill Ventures as a funder
Investment thesis
Militia Hill Ventures focuses on creating, building, and investing in life sciences companies, particularly in therapeutics with clear unmet medical needs. The firm emphasizes a hands-on approach to company formation, leveraging its deep connections within the Philadelphia biotech ecosystem.
Focus narrative
Militia Hill Ventures invests primarily in life sciences companies, employing an active 'build' approach to foster high-quality, fast-growing enterprises. The firm leverages its extensive network and domain expertise to support portfolio companies in their development of innovative therapies, particularly in gene therapy, regenerative medicine, and cancer immunotherapy.
Value beyond capital
Militia Hill Ventures adds value to its portfolio companies through a hands-on approach, leveraging its extensive network and relationships within the life sciences sector. The firm provides operational support, strategic guidance, and access to resources that help accelerate the development of innovative therapies.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 5
- Recorded notable exits
- Immunome
Portfolio context
Notable portfolio companies include: Spirovant Sciences: Developing a gene therapy for cystic fibrosis, aiming to provide the first curative treatment for the disease. Immunome: Focuses on discovering and developing novel targets and therapies for cancer using the human immune system. Tmunity Therapeutics: A biotherapeutics company working on next-generation T cell immunotherapy for cancer, infectious diseases, and autoimmune diseases. Eliksa Therapeutics: A regenerative medicine company with a clinical pipeline addressing unmet medical needs in ocular and cardiovascular indications. RiboNova: A biopharmaceutical company developing a small molecule drug for inherited mitochondrial disease and a proprietary drug discovery platform.
Common questions
What to know about Militia Hill Ventures
Upseed classifies Militia Hill Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 24, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.